InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-28.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by ALTMAN MICHAEL SETH. Officer active across 4 companies, notably Nautilus Biotechnology, Inc.. Aggregated, 6 disclosures have been recorded. Activity tracked since 15 July 2021. The latest transaction was disclosed on 13 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
499,000 sharesClass A ordinary sharesSEC:0001140361-24-035164:0
286,250 shares@ US$10.00100.0% of flowClass A ordinary sharesSEC:0001140361-24-030023:0
499,000 shares@ US$10.0050.0% of flowClass A ordinary sharesSEC:0001140361-21-024476
499,000 shares@ US$10.0050.0% of flowClass A ordinary sharesSEC:0001140361-21-024476:0
3,647,500 sharesCommon StockSEC:0001140361-21-020674:0
3,647,500 sharesCommon StockSEC:0001140361-21-020674
6 of 6 declarations
